chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Dizziness, Dysarthria, Feeling abnormal, Illness
Clinical narrative: Brain aneurysm; Can't speak, speech problems; Diagnosed with bilateral paresis of the vocal cord; Diagnosed with dysarthria/Very slurred; First Dose: 17Feb2021/Second dose: 12Aug2021; Felt a rush to the brain, wanted to cough; Tingly in the mouth; Tingly in the mouth, throat area; Problems with the head, dizziness; She is very sick; This is a spontaneous report from a contactable consumer (Patients mother)   A 46-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0186) on 12Aug2021 at single dose via an unspecified route of administration on arm for COVID-19 immunization. Relevant medical history included kidney problems that occurred after infection in 2020. Concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ENG200, age of vaccination 45 years) on 17Feb2021 and experienced throat irritation, oral pruritus, chest pain, oropharyngeal discomfort, aphonia, speech disorder, secretion discharge, cough, upper-airway cough syndrome, hypersensitivity, skin discoloration, white blood cell count increased, red blood cell count decreased, haemoglobin decreased, blood potassium decreased, blood chloride decreased, blood creatinine increased, blood glucose increased, alanine aminotransferase increased, dysphonia, gerd. On 12Aug2021 about 2 or 3 minutes, right after the second dose the patient a rush to the brain, then she wanted to cough. She started getting very tingly. She clarified that her mouth was tingly in the throat area. It lasted until now.  She had it at the allergist office. They had told her because of the first incident that happened, she should take the vaccine in the presence of the allergist.  She can't speak, and is sorry to say but, it is like someone who is mentally challenged and verbally challenged. It has stayed the same and she is not able to speak. Her diagnosis was bilateral paresis of the vocal cord, dysarthria, brain aneurysm.  This diagnosis was because  the patient cannot verbalize clearly. The patient's verbal language right now is very slurred and very, like a person who is mentally disabled with speech problems. The allergist gave her some prednisone and allergy medication to take. It was not very much medication. Then, they sent her home. It wasn't getting much better. Then, she started getting sicker and had problems with the head. Reporter informed that the problems with the head started on the same day, 12Aug2021 and never went away. It just stayed the same and did not bring the speech back. At the time of the reporting outcome for the event Felt a rush to the brain, wanted to cough' and Brain aneurysm,  Problems with the head, dizziness and inappropriate schedule of vaccine administered was unknown, while outcome of other reported evens was not recovered.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Intracranial aneurysm, Paraesthesia oral, Pharyngeal paraesthesia, Speech disorder
Clinical narrative: Brain aneurysm; Can't speak, speech problems; Diagnosed with bilateral paresis of the vocal cord; Diagnosed with dysarthria/Very slurred; First Dose: 17Feb2021/Second dose: 12Aug2021; Felt a rush to the brain, wanted to cough; Tingly in the mouth; Tingly in the mouth, throat area; Problems with the head, dizziness; She is very sick; This is a spontaneous report from a contactable consumer (Patients mother)   A 46-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0186) on 12Aug2021 at single dose via an unspecified route of administration on arm for COVID-19 immunization. Relevant medical history included kidney problems that occurred after infection in 2020. Concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ENG200, age of vaccination 45 years) on 17Feb2021 and experienced throat irritation, oral pruritus, chest pain, oropharyngeal discomfort, aphonia, speech disorder, secretion discharge, cough, upper-airway cough syndrome, hypersensitivity, skin discoloration, white blood cell count increased, red blood cell count decreased, haemoglobin decreased, blood potassium decreased, blood chloride decreased, blood creatinine increased, blood glucose increased, alanine aminotransferase increased, dysphonia, gerd. On 12Aug2021 about 2 or 3 minutes, right after the second dose the patient a rush to the brain, then she wanted to cough. She started getting very tingly. She clarified that her mouth was tingly in the throat area. It lasted until now.  She had it at the allergist office. They had told her because of the first incident that happened, she should take the vaccine in the presence of the allergist.  She can't speak, and is sorry to say but, it is like someone who is mentally challenged and verbally challenged. It has stayed the same and she is not able to speak. Her diagnosis was bilateral paresis of the vocal cord, dysarthria, brain aneurysm.  This diagnosis was because  the patient cannot verbalize clearly. The patient's verbal language right now is very slurred and very, like a person who is mentally disabled with speech problems. The allergist gave her some prednisone and allergy medication to take. It was not very much medication. Then, they sent her home. It wasn't getting much better. Then, she started getting sicker and had problems with the head. Reporter informed that the problems with the head started on the same day, 12Aug2021 and never went away. It just stayed the same and did not bring the speech back. At the time of the reporting outcome for the event Felt a rush to the brain, wanted to cough' and Brain aneurysm,  Problems with the head, dizziness and inappropriate schedule of vaccine administered was unknown, while outcome of other reported evens was not recovered.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vocal cord paralysis
Clinical narrative: Brain aneurysm; Can't speak, speech problems; Diagnosed with bilateral paresis of the vocal cord; Diagnosed with dysarthria/Very slurred; First Dose: 17Feb2021/Second dose: 12Aug2021; Felt a rush to the brain, wanted to cough; Tingly in the mouth; Tingly in the mouth, throat area; Problems with the head, dizziness; She is very sick; This is a spontaneous report from a contactable consumer (Patients mother)   A 46-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0186) on 12Aug2021 at single dose via an unspecified route of administration on arm for COVID-19 immunization. Relevant medical history included kidney problems that occurred after infection in 2020. Concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ENG200, age of vaccination 45 years) on 17Feb2021 and experienced throat irritation, oral pruritus, chest pain, oropharyngeal discomfort, aphonia, speech disorder, secretion discharge, cough, upper-airway cough syndrome, hypersensitivity, skin discoloration, white blood cell count increased, red blood cell count decreased, haemoglobin decreased, blood potassium decreased, blood chloride decreased, blood creatinine increased, blood glucose increased, alanine aminotransferase increased, dysphonia, gerd. On 12Aug2021 about 2 or 3 minutes, right after the second dose the patient a rush to the brain, then she wanted to cough. She started getting very tingly. She clarified that her mouth was tingly in the throat area. It lasted until now.  She had it at the allergist office. They had told her because of the first incident that happened, she should take the vaccine in the presence of the allergist.  She can't speak, and is sorry to say but, it is like someone who is mentally challenged and verbally challenged. It has stayed the same and she is not able to speak. Her diagnosis was bilateral paresis of the vocal cord, dysarthria, brain aneurysm.  This diagnosis was because  the patient cannot verbalize clearly. The patient's verbal language right now is very slurred and very, like a person who is mentally disabled with speech problems. The allergist gave her some prednisone and allergy medication to take. It was not very much medication. Then, they sent her home. It wasn't getting much better. Then, she started getting sicker and had problems with the head. Reporter informed that the problems with the head started on the same day, 12Aug2021 and never went away. It just stayed the same and did not bring the speech back. At the time of the reporting outcome for the event Felt a rush to the brain, wanted to cough' and Brain aneurysm,  Problems with the head, dizziness and inappropriate schedule of vaccine administered was unknown, while outcome of other reported evens was not recovered.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: SOB and hypoxia, increased oxygen demand
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hypoxia, Oxygen saturation decreased
Clinical narrative: SOB and hypoxia, increased oxygen demand
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Catheter placement, Discomfort, Dyspepsia, Ear discomfort
Clinical narrative: urinary retention; Nerve pain; Neuropathy; Allergic-like reaction on ears and scalp; Allergic-like reaction on ears and scalp; Nerve pains at waist within days; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0150), dose 1 via an unspecified route of administration on 14Apr2021 at 13:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was healthy before vaccination. On 15Apr2021 the patient experienced nerve pain, neuropathy, urinary retention. Symptoms began within 12 hours of shot with allergic-like reaction on ears and scalp. Nerve pains at waist within days. Severe nerve pain in pelvic area, buttocks, legs, with urinary retention by 3 to 4 weeks post vaccine. Continuing to present, 06Sep2021. Adverse events resulted in doctor or other healthcare professional office/clinic visit, disability, or permanent damage. As therapeutic measures as a result of urinary retention, nerve pain, neuropathy, allergic-like reaction on ears and scalp, allergic-like reaction on ears and scalp, nerve pains at waist within days, severe nerve pain in pelvic area, buttocks, legs the patient received prednisone, 2 rounds, Antihistamines, Gabapentin. The outcome of the events was reported as not resolved.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Exercise tolerance decreased, Eye pain, Genital pain, Hypoaesthesia, Loss of personal independence in daily activities
Clinical narrative: urinary retention; Nerve pain; Neuropathy; Allergic-like reaction on ears and scalp; Allergic-like reaction on ears and scalp; Nerve pains at waist within days; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0150), dose 1 via an unspecified route of administration on 14Apr2021 at 13:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was healthy before vaccination. On 15Apr2021 the patient experienced nerve pain, neuropathy, urinary retention. Symptoms began within 12 hours of shot with allergic-like reaction on ears and scalp. Nerve pains at waist within days. Severe nerve pain in pelvic area, buttocks, legs, with urinary retention by 3 to 4 weeks post vaccine. Continuing to present, 06Sep2021. Adverse events resulted in doctor or other healthcare professional office/clinic visit, disability, or permanent damage. As therapeutic measures as a result of urinary retention, nerve pain, neuropathy, allergic-like reaction on ears and scalp, allergic-like reaction on ears and scalp, nerve pains at waist within days, severe nerve pain in pelvic area, buttocks, legs the patient received prednisone, 2 rounds, Antihistamines, Gabapentin. The outcome of the events was reported as not resolved.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal pain, Neuralgia, Neuropathy peripheral, Nutritional condition abnormal, Pain
Clinical narrative: urinary retention; Nerve pain; Neuropathy; Allergic-like reaction on ears and scalp; Allergic-like reaction on ears and scalp; Nerve pains at waist within days; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0150), dose 1 via an unspecified route of administration on 14Apr2021 at 13:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was healthy before vaccination. On 15Apr2021 the patient experienced nerve pain, neuropathy, urinary retention. Symptoms began within 12 hours of shot with allergic-like reaction on ears and scalp. Nerve pains at waist within days. Severe nerve pain in pelvic area, buttocks, legs, with urinary retention by 3 to 4 weeks post vaccine. Continuing to present, 06Sep2021. Adverse events resulted in doctor or other healthcare professional office/clinic visit, disability, or permanent damage. As therapeutic measures as a result of urinary retention, nerve pain, neuropathy, allergic-like reaction on ears and scalp, allergic-like reaction on ears and scalp, nerve pains at waist within days, severe nerve pain in pelvic area, buttocks, legs the patient received prednisone, 2 rounds, Antihistamines, Gabapentin. The outcome of the events was reported as not resolved.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia, Pelvic floor dysfunction, Pruritus, Rhinalgia
Clinical narrative: urinary retention; Nerve pain; Neuropathy; Allergic-like reaction on ears and scalp; Allergic-like reaction on ears and scalp; Nerve pains at waist within days; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0150), dose 1 via an unspecified route of administration on 14Apr2021 at 13:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was healthy before vaccination. On 15Apr2021 the patient experienced nerve pain, neuropathy, urinary retention. Symptoms began within 12 hours of shot with allergic-like reaction on ears and scalp. Nerve pains at waist within days. Severe nerve pain in pelvic area, buttocks, legs, with urinary retention by 3 to 4 weeks post vaccine. Continuing to present, 06Sep2021. Adverse events resulted in doctor or other healthcare professional office/clinic visit, disability, or permanent damage. As therapeutic measures as a result of urinary retention, nerve pain, neuropathy, allergic-like reaction on ears and scalp, allergic-like reaction on ears and scalp, nerve pains at waist within days, severe nerve pain in pelvic area, buttocks, legs the patient received prednisone, 2 rounds, Antihistamines, Gabapentin. The outcome of the events was reported as not resolved.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder, Urinary retention
Clinical narrative: urinary retention; Nerve pain; Neuropathy; Allergic-like reaction on ears and scalp; Allergic-like reaction on ears and scalp; Nerve pains at waist within days; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0150), dose 1 via an unspecified route of administration on 14Apr2021 at 13:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was healthy before vaccination. On 15Apr2021 the patient experienced nerve pain, neuropathy, urinary retention. Symptoms began within 12 hours of shot with allergic-like reaction on ears and scalp. Nerve pains at waist within days. Severe nerve pain in pelvic area, buttocks, legs, with urinary retention by 3 to 4 weeks post vaccine. Continuing to present, 06Sep2021. Adverse events resulted in doctor or other healthcare professional office/clinic visit, disability, or permanent damage. As therapeutic measures as a result of urinary retention, nerve pain, neuropathy, allergic-like reaction on ears and scalp, allergic-like reaction on ears and scalp, nerve pains at waist within days, severe nerve pain in pelvic area, buttocks, legs the patient received prednisone, 2 rounds, Antihistamines, Gabapentin. The outcome of the events was reported as not resolved.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear disorder, Musculoskeletal pain, Neuralgia, Neuropathy peripheral, Pain
Clinical narrative: urinary retention; Nerve pain; Neuropathy; Allergic-like reaction on ears and scalp; Allergic-like reaction on ears and scalp; Nerve pains at waist within days; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0150), dose 1 via an unspecified route of administration on 14Apr2021 at 13:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was healthy before vaccination. On 15Apr2021 the patient experienced nerve pain, neuropathy, urinary retention. Symptoms began within 12 hours of shot with allergic-like reaction on ears and scalp. Nerve pains at waist within days. Severe nerve pain in pelvic area, buttocks, legs, with urinary retention by 3 to 4 weeks post vaccine. Continuing to present, 06Sep2021. Adverse events resulted in doctor or other healthcare professional office/clinic visit, disability, or permanent damage. As therapeutic measures as a result of urinary retention, nerve pain, neuropathy, allergic-like reaction on ears and scalp, allergic-like reaction on ears and scalp, nerve pains at waist within days, severe nerve pain in pelvic area, buttocks, legs the patient received prednisone, 2 rounds, Antihistamines, Gabapentin. The outcome of the events was reported as not resolved.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pelvic pain, Skin disorder, Urinary retention
Clinical narrative: urinary retention; Nerve pain; Neuropathy; Allergic-like reaction on ears and scalp; Allergic-like reaction on ears and scalp; Nerve pains at waist within days; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; Severe nerve pain in pelvic area, buttocks, legs; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0150), dose 1 via an unspecified route of administration on 14Apr2021 at 13:30 (at the age of 55-year-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was healthy before vaccination. On 15Apr2021 the patient experienced nerve pain, neuropathy, urinary retention. Symptoms began within 12 hours of shot with allergic-like reaction on ears and scalp. Nerve pains at waist within days. Severe nerve pain in pelvic area, buttocks, legs, with urinary retention by 3 to 4 weeks post vaccine. Continuing to present, 06Sep2021. Adverse events resulted in doctor or other healthcare professional office/clinic visit, disability, or permanent damage. As therapeutic measures as a result of urinary retention, nerve pain, neuropathy, allergic-like reaction on ears and scalp, allergic-like reaction on ears and scalp, nerve pains at waist within days, severe nerve pain in pelvic area, buttocks, legs the patient received prednisone, 2 rounds, Antihistamines, Gabapentin. The outcome of the events was reported as not resolved.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Back pain, Chest pain, Crying, Hallucination, auditory
Clinical narrative: auditory hallucination; I don't know if it was a panic attack or a little heart issue; I don't know if it was a panic attack or a little heart issue; my chest hurt badly in the middle; my back hurt in the middle; my head hurt; my legs hurt; started crying; very strange reaction; anxiety; This is a spontaneous report from a contactable consumer (the patient reported for self). A 57-years-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: FE3592), via an unspecified route of administration, administered in arm right on 04Sep2021 10:30 as dose 1, single (at the age of 57-years-old) for covid-19 immunization. Medical history included panic attack (22 years ago). There were no known allergies. There were no concomitant medications. other medications in two weeks None. The patient did not receive any other vaccine in four weeks and also patient did not receive any other medication in two weeks. The patient had not diagnosed with COVID prior to vaccination. It was reported that the about 9 hours after the vaccine (on 04Sep2021 19:30), patient had a very strange reaction. She did not know if it was a panic attack or a little heart issue. Suddenly her chest hurt badly in the middle, and then back hurt in the middle, and then head hurt, and then legs hurt. Patient was full of anxiety and started crying. It lasted about 10 or 15 minutes and then everything went away and patient was back to perfectly normal. A few seconds before this episode patient had an auditory hallucination which was the first and only one ever had. Nothing else unusual or out of the ordinary happened on this day except for the vaccine. The patient was in a normal good mood and had a normal day before it happened, and it went away as fast as it came after about 10 - 15 minutes. The patient did not receive any treatment for the events. Patient was not tested for COVID post vaccination. The outcome of all the events had recovered.  Device Date : 06Sep2021  Follow-up attempts were completed. No further information was expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: auditory hallucination; I don't know if it was a panic attack or a little heart issue; I don't know if it was a panic attack or a little heart issue; my chest hurt badly in the middle; my back hurt in the middle; my head hurt; my legs hurt; started crying; very strange reaction; anxiety; This is a spontaneous report from a contactable consumer (the patient reported for self). A 57-years-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: FE3592), via an unspecified route of administration, administered in arm right on 04Sep2021 10:30 as dose 1, single (at the age of 57-years-old) for covid-19 immunization. Medical history included panic attack (22 years ago). There were no known allergies. There were no concomitant medications. other medications in two weeks None. The patient did not receive any other vaccine in four weeks and also patient did not receive any other medication in two weeks. The patient had not diagnosed with COVID prior to vaccination. It was reported that the about 9 hours after the vaccine (on 04Sep2021 19:30), patient had a very strange reaction. She did not know if it was a panic attack or a little heart issue. Suddenly her chest hurt badly in the middle, and then back hurt in the middle, and then head hurt, and then legs hurt. Patient was full of anxiety and started crying. It lasted about 10 or 15 minutes and then everything went away and patient was back to perfectly normal. A few seconds before this episode patient had an auditory hallucination which was the first and only one ever had. Nothing else unusual or out of the ordinary happened on this day except for the vaccine. The patient was in a normal good mood and had a normal day before it happened, and it went away as fast as it came after about 10 - 15 minutes. The patient did not receive any treatment for the events. Patient was not tested for COVID post vaccination. The outcome of all the events had recovered.  Device Date : 06Sep2021  Follow-up attempts were completed. No further information was expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Back pain, Cardiac disorder, Chest pain, Crying
Clinical narrative: auditory hallucination; I don't know if it was a panic attack or a little heart issue; I don't know if it was a panic attack or a little heart issue; my chest hurt badly in the middle; my back hurt in the middle; my head hurt; my legs hurt; started crying; very strange reaction; anxiety; This is a spontaneous report from a contactable consumer (the patient reported for self). A 57-years-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: FE3592), via an unspecified route of administration, administered in arm right on 04Sep2021 10:30 as dose 1, single (at the age of 57-years-old) for covid-19 immunization. Medical history included panic attack (22 years ago). There were no known allergies. There were no concomitant medications. other medications in two weeks None. The patient did not receive any other vaccine in four weeks and also patient did not receive any other medication in two weeks. The patient had not diagnosed with COVID prior to vaccination. It was reported that the about 9 hours after the vaccine (on 04Sep2021 19:30), patient had a very strange reaction. She did not know if it was a panic attack or a little heart issue. Suddenly her chest hurt badly in the middle, and then back hurt in the middle, and then head hurt, and then legs hurt. Patient was full of anxiety and started crying. It lasted about 10 or 15 minutes and then everything went away and patient was back to perfectly normal. A few seconds before this episode patient had an auditory hallucination which was the first and only one ever had. Nothing else unusual or out of the ordinary happened on this day except for the vaccine. The patient was in a normal good mood and had a normal day before it happened, and it went away as fast as it came after about 10 - 15 minutes. The patient did not receive any treatment for the events. Patient was not tested for COVID post vaccination. The outcome of all the events had recovered.  Device Date : 06Sep2021  Follow-up attempts were completed. No further information was expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Hallucination, auditory, Headache, Pain in extremity, Panic attack
Clinical narrative: auditory hallucination; I don't know if it was a panic attack or a little heart issue; I don't know if it was a panic attack or a little heart issue; my chest hurt badly in the middle; my back hurt in the middle; my head hurt; my legs hurt; started crying; very strange reaction; anxiety; This is a spontaneous report from a contactable consumer (the patient reported for self). A 57-years-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: FE3592), via an unspecified route of administration, administered in arm right on 04Sep2021 10:30 as dose 1, single (at the age of 57-years-old) for covid-19 immunization. Medical history included panic attack (22 years ago). There were no known allergies. There were no concomitant medications. other medications in two weeks None. The patient did not receive any other vaccine in four weeks and also patient did not receive any other medication in two weeks. The patient had not diagnosed with COVID prior to vaccination. It was reported that the about 9 hours after the vaccine (on 04Sep2021 19:30), patient had a very strange reaction. She did not know if it was a panic attack or a little heart issue. Suddenly her chest hurt badly in the middle, and then back hurt in the middle, and then head hurt, and then legs hurt. Patient was full of anxiety and started crying. It lasted about 10 or 15 minutes and then everything went away and patient was back to perfectly normal. A few seconds before this episode patient had an auditory hallucination which was the first and only one ever had. Nothing else unusual or out of the ordinary happened on this day except for the vaccine. The patient was in a normal good mood and had a normal day before it happened, and it went away as fast as it came after about 10 - 15 minutes. The patient did not receive any treatment for the events. Patient was not tested for COVID post vaccination. The outcome of all the events had recovered.  Device Date : 06Sep2021  Follow-up attempts were completed. No further information was expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chest discomfort, Computerised tomogram, Echocardiogram abnormal, Fatigue
Clinical narrative: I received a diagnosis of pericarditis and am recovering with medication for that.; to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination; to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination; to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination; This is a spontaneous report from a non-contactable consumer or other non hcp. A 52-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: Ew0171) via an unspecified route of administration on 21Apr2021 12:15 (age at vaccination 52years old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number was not reported) via an unspecified route of administration on unspecified date (age at vaccination 52years old) as single dose for covid-19 immunisation. The patient experienced i received a diagnosis of pericarditis and am recovering with medication for that, to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination on an unspecified date. Clinical course was reported as I am a serious athlete and went from feeling perfectly healthy and swimming two miles a day several times a week and working out at the gym the rest of the days, and winning swimming races, to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination. I received a diagnosis of pericarditis and am recovering with medication for that. I have elderly parents and have gotten tested regularly for covid for their protection and never tested positive and also never had covid symptoms. Therapeutic measures were taken as a result of i received a diagnosis of pericarditis and am recovering with medication for that, to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination. The clinical outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pericarditis, Ultrasound abdomen
Clinical narrative: I received a diagnosis of pericarditis and am recovering with medication for that.; to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination; to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination; to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination; This is a spontaneous report from a non-contactable consumer or other non hcp. A 52-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: Ew0171) via an unspecified route of administration on 21Apr2021 12:15 (age at vaccination 52years old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number was not reported) via an unspecified route of administration on unspecified date (age at vaccination 52years old) as single dose for covid-19 immunisation. The patient experienced i received a diagnosis of pericarditis and am recovering with medication for that, to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination on an unspecified date. Clinical course was reported as I am a serious athlete and went from feeling perfectly healthy and swimming two miles a day several times a week and working out at the gym the rest of the days, and winning swimming races, to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination. I received a diagnosis of pericarditis and am recovering with medication for that. I have elderly parents and have gotten tested regularly for covid for their protection and never tested positive and also never had covid symptoms. Therapeutic measures were taken as a result of i received a diagnosis of pericarditis and am recovering with medication for that, to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination. The clinical outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chest discomfort, Fatigue, Pericarditis
Clinical narrative: I received a diagnosis of pericarditis and am recovering with medication for that.; to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination; to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination; to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination; This is a spontaneous report from a non-contactable consumer or other non hcp. A 52-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: Ew0171) via an unspecified route of administration on 21Apr2021 12:15 (age at vaccination 52years old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number was not reported) via an unspecified route of administration on unspecified date (age at vaccination 52years old) as single dose for covid-19 immunisation. The patient experienced i received a diagnosis of pericarditis and am recovering with medication for that, to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination on an unspecified date. Clinical course was reported as I am a serious athlete and went from feeling perfectly healthy and swimming two miles a day several times a week and working out at the gym the rest of the days, and winning swimming races, to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination. I received a diagnosis of pericarditis and am recovering with medication for that. I have elderly parents and have gotten tested regularly for covid for their protection and never tested positive and also never had covid symptoms. Therapeutic measures were taken as a result of i received a diagnosis of pericarditis and am recovering with medication for that, to suddenly suffering from debilitating fatigue, chest heaviness and upper abdominal pain 10 weeks after my second vaccination. The clinical outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Abdominal pain, Computerised tomogram normal, Crying, Endoscopy abnormal
Clinical narrative: it started with abdominal cramping then severe stabbing pain all over my right and left abdomen.; my stomach is either partially or fully paralyzed; Unable to eat; Nausea; Painful bloating; This is a spontaneous report from a contactable Consumer (patient, self-reporting). A 24-year-old (non-pregnant) female patient received a first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), dose 1 via unspecified route of administration in left arm on 09Apr2021 (at the age of 24-year-old) as single dose for COVID-19 immunization in Hospital. The patient medical history includes COVID-19 on an unspecified onset an unknown stop date and concomitant medications were not reported. On 16May2021, after the vaccination, the patient experienced abdominal cramping then severe stabbing pain all over her right and left abdomen. Painful bloating and unable to eat without getting extremely full paired with nausea. Gastric emptying study came back abnormal thus finding out her stomach is either partially or fully paralysed. Adverse event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and Hospitalization. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported) dose 2 via an unspecified route of administration on 27Jul2021 as single dose for COVID-19 immunization. Patient was diagnosed with COVID prior vaccination. No known allergies reported. No other vaccines were taken in four weeks of vaccination and no other medications were taken in two weeks of vaccination. The patient lab data includes Gastric emptying study on an unspecified date which showed abnormal results stomach is either partially or fully paralysed. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flank pain, Gastric emptying study, Impaired gastric emptying, Laboratory test normal, Loss of personal independence in daily activities
Clinical narrative: it started with abdominal cramping then severe stabbing pain all over my right and left abdomen.; my stomach is either partially or fully paralyzed; Unable to eat; Nausea; Painful bloating; This is a spontaneous report from a contactable Consumer (patient, self-reporting). A 24-year-old (non-pregnant) female patient received a first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), dose 1 via unspecified route of administration in left arm on 09Apr2021 (at the age of 24-year-old) as single dose for COVID-19 immunization in Hospital. The patient medical history includes COVID-19 on an unspecified onset an unknown stop date and concomitant medications were not reported. On 16May2021, after the vaccination, the patient experienced abdominal cramping then severe stabbing pain all over her right and left abdomen. Painful bloating and unable to eat without getting extremely full paired with nausea. Gastric emptying study came back abnormal thus finding out her stomach is either partially or fully paralysed. Adverse event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and Hospitalization. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported) dose 2 via an unspecified route of administration on 27Jul2021 as single dose for COVID-19 immunization. Patient was diagnosed with COVID prior vaccination. No known allergies reported. No other vaccines were taken in four weeks of vaccination and no other medications were taken in two weeks of vaccination. The patient lab data includes Gastric emptying study on an unspecified date which showed abnormal results stomach is either partially or fully paralysed. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Pain, Ultrasound scan normal, Urine analysis normal, X-ray normal
Clinical narrative: it started with abdominal cramping then severe stabbing pain all over my right and left abdomen.; my stomach is either partially or fully paralyzed; Unable to eat; Nausea; Painful bloating; This is a spontaneous report from a contactable Consumer (patient, self-reporting). A 24-year-old (non-pregnant) female patient received a first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), dose 1 via unspecified route of administration in left arm on 09Apr2021 (at the age of 24-year-old) as single dose for COVID-19 immunization in Hospital. The patient medical history includes COVID-19 on an unspecified onset an unknown stop date and concomitant medications were not reported. On 16May2021, after the vaccination, the patient experienced abdominal cramping then severe stabbing pain all over her right and left abdomen. Painful bloating and unable to eat without getting extremely full paired with nausea. Gastric emptying study came back abnormal thus finding out her stomach is either partially or fully paralysed. Adverse event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and Hospitalization. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported) dose 2 via an unspecified route of administration on 27Jul2021 as single dose for COVID-19 immunization. Patient was diagnosed with COVID prior vaccination. No known allergies reported. No other vaccines were taken in four weeks of vaccination and no other medications were taken in two weeks of vaccination. The patient lab data includes Gastric emptying study on an unspecified date which showed abnormal results stomach is either partially or fully paralysed. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.